These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29537989)

  • 1. Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats.
    Horsley RR; Páleníček T; Kolin J; Valeš K
    Behav Pharmacol; 2018 Sep; 29(6):530-536. PubMed ID: 29537989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.
    Tylš F; Páleníček T; Kadeřábek L; Lipski M; Kubešová A; Horáček J
    Behav Pharmacol; 2016 Jun; 27(4):309-20. PubMed ID: 26461483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.
    Wąsik A; Białoń M; Żarnowska M; Antkiewicz-Michaluk L
    Pharmacol Biochem Behav; 2019 Jun; 181():17-27. PubMed ID: 30965047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress and Ketamine, Bimodal Influence on Cognitive Functions.
    Trofimiuk E; Wielgat P; Braszko JJ; Car H
    Behav Brain Res; 2019 Mar; 360():354-364. PubMed ID: 30562568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats.
    Silvestre JS; Nadal R; Pallarés M; Ferré N
    Depress Anxiety; 1997; 5(1):29-33. PubMed ID: 9250438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats.
    Guarraci FA; Gonzalez CMF; Lucero D; Womble PD; Abdel-Rahim H; DeVore J; Kunkel MN; Quadlander E; Stinnett M; Boyette-Davis J
    Pharmacol Biochem Behav; 2018 Feb; 165():36-44. PubMed ID: 29273457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
    Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E
    Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.
    Higgins GA; Carroll NK; Brown M; MacMillan C; Silenieks LB; Thevarkunnel S; Izhakova J; Magomedova L; DeLannoy I; Sellers EM
    Front Pharmacol; 2021; 12():640241. PubMed ID: 33716753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.
    Sakashita Y; Abe K; Katagiri N; Kambe T; Saitoh T; Utsunomiya I; Horiguchi Y; Taguchi K
    Biol Pharm Bull; 2015; 38(1):134-8. PubMed ID: 25342005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.
    Brown RT; Nicholas CR; Cozzi NV; Gassman MC; Cooper KM; Muller D; Thomas CD; Hetzel SJ; Henriquez KM; Ribaudo AS; Hutson PR
    Clin Pharmacokinet; 2017 Dec; 56(12):1543-1554. PubMed ID: 28353056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.
    Marschall J; Fejer G; Lempe P; Prochazkova L; Kuchar M; Hajkova K; van Elk M
    J Psychopharmacol; 2022 Jan; 36(1):97-113. PubMed ID: 34915762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.
    Spain A; Howarth C; Khrapitchev AA; Sharp T; Sibson NR; Martin C
    Neuropharmacology; 2015 Dec; 99():210-20. PubMed ID: 26192543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of ketamine and toxic interactions with psychostimulants.
    Hayase T; Yamamoto Y; Yamamoto K
    BMC Neurosci; 2006 Mar; 7():25. PubMed ID: 16542420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of ethanol and ketamine in the elevated plus-maze test in Wistar rats undergoing a chronic oral voluntary consumption procedure.
    Silvestre JS; Pallarés M; Nadal R; Ferré N
    J Psychopharmacol; 2002 Dec; 16(4):305-12. PubMed ID: 12503829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats.
    Braida D; Pozzi M; Cavallini R; Sala M
    Behav Neurosci; 2002 Apr; 116(2):298-304. PubMed ID: 11996315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L; Güven O
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.